CompoAtlas

Xinta NG

Natural health product licensed in Canada

Licence holder
Visalus Inc.
NPN or DIN-HM
80041176
Status
Active licence
Licence date
21 March 2013
Revision date
Not provided
Form
Sachet de thé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine C

Source : Ascorbate de sodium

60 milligrammeNot calculated

Non-medicinal ingredients

Maltodextrine, Feuille de Stevia rebaudiana, Silicate de calcium, Saveur de fruits des champs, Pomme, Groseille verte indienne, Extrait de raisin, Jus de canne à sucre, Maqui berry, Saveur de fruit de la passion, Extrait de fruit de Siraitia Grosvenorii, Extrait de fruit d'açaï, Saveur de grenade, Baie d'Aristotelia chilensis, Extrait de cassis, Fruit de Baobab

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 tea bag1 day

Uses authorised in Canada

Use as an antioxidant for the maintenance of good health. Helps the body to metabolize fats and proteins, in the development and maintenance of bones, cartilage, dental health and in connective tissue formation and in wound healing.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80041176

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line